Optumrx — D&A
Business Segments · D&AUnitedHealth Group Optumrx — D&A decreased by 2.8% to $210.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 0.5%, from $209.00M to $210.00M. Over 3 years (FY 2021 to FY 2024), Optumrx — D&A shows an upward trend with a 9.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase may indicate significant recent capital investments or the amortization of newly acquired intangible assets, while a decrease could suggest aging infrastructure or a reduction in acquisition-related intangible write-offs.
Detailed definition
This metric represents the non-cash expense allocated to the Optum Rx pharmacy care services segment for the wear and te...
Peer comparison
Comparable to depreciation and amortization expenses reported by other pharmacy benefit managers and healthcare services providers, though it is highly dependent on the company's specific M&A history and capital investment cycle.
unh_segment_optum_rx_depreciation_and_amortizationHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $149.25M | $149.25M | $149.25M | $160.75M | $160.75M | $160.75M | $160.75M | $174.00M | $174.00M | $174.00M | $174.00M | $180.00M | $206.00M | $209.00M | $198.00M | $211.00M | $216.00M | $210.00M |
| QoQ Change | — | +0.0% | +0.0% | +7.7% | +0.0% | +0.0% | +0.0% | +8.2% | +0.0% | +0.0% | +0.0% | +3.4% | +14.4% | +1.5% | -5.3% | +6.6% | +2.4% | -2.8% |
| YoY Change | — | — | — | — | +7.7% | +7.7% | +7.7% | +8.2% | +8.2% | +8.2% | +8.2% | +3.4% | +18.4% | +20.1% | +13.8% | +17.2% | +4.9% | +0.5% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is UnitedHealth Group's optumrx — d&a?
- UnitedHealth Group (UNH) reported optumrx — d&a of $210.00M in Q3 2025.
- How has UnitedHealth Group's optumrx — d&a changed year-over-year?
- UnitedHealth Group's optumrx — d&a increased by 0.5% year-over-year, from $209.00M to $210.00M.
- What is the long-term trend for UnitedHealth Group's optumrx — d&a?
- Over 3 years (2021 to 2024), UnitedHealth Group's optumrx — d&a has grown at a 9.9% compound annual growth rate (CAGR), from $597.00M to $793.00M.
- What does optumrx — d&a mean?
- The non-cash cost of using up physical equipment and intangible assets within the pharmacy care services business.